Project Grant R00AR080757

Award Date 7/1/24
Completion Date 6/30/27
Dollars Obligated $1M
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14642, USA
Similar Awards
This $360,580 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research to develop an engineered extracellular matrix (EECM) that can promote regenerative healing in tendons. The University of Oregon will fabricate anisotropic PEG hydrogel-based EECM scaffolds and evaluate their ability to guide the alignment and matrix deposition of human...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $501,450 to The Washington University to conduct research on regulating tendon repair using stem cell-derived extracellular vesicles. The study aims to identify the specific subpopulation and active cargo molecules of extracellular vesicles that can enhance tendon healing and avoid...
This federal Project Grant award of $621,703, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to understand the mechanisms of tendon repair and develop treatments for tendinopathy. The award, with a period of performance from Sep 1, 2024 to Aug 31, 2029, will fund Cornell University's investigation into how changes in glycosaminoglycans (GAGs)...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $570,878 to the University of Rochester to research the modulation of myofibroblast dynamics during tendon healing. The award aims to define the efficacy of pharmacological activation of the GPR68 receptor to regulate the interaction between macrophages and myofibroblasts, which are key...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $158,912.00 to The General Hospital Corporation (d.b.a. Massachusetts General Hospital) to investigate the role of Wnt signaling in the mechanical maturation of tendons. The goal is to elucidate the function of Wnt signaling in postnatal tendon maturation and test if mechanical cues...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $499,229 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on the mechanisms underlying adult tendon regeneration in the zebrafish model. The research aims to investigate the relationship between TGF-beta signaling and muscle activity in tendon...
This $464,315 Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research at the University of Rochester to investigate the role of the L-type Ca2+ channel Cav1.2 in the development of Achilles tendinopathy. The research aims to elucidate the cellular and molecular mechanisms underlying Cav1.2 expression and Ca2+ signaling in Achilles tendon...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $549,437 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, effective September 1, 2024 through June 30, 2029, aims to develop a novel therapy that leverages the Hedgehog signaling pathway to improve tendon-to-bone...
This Project Grant award, valued at $359,133.00, was issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports the generation of new genetic tools to enable more targeted and specific analysis of tendon and musculoskeletal tissues in mice. The goal is to develop constitutive and inducible FLP alleles that can be used in combination with existing...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $1,488,960.00 over 5 years to the University of Southern California (USC) to conduct research on the role of connective tissue progenitor cells in the development of the temporomandibular joint (TMJ). The research aims to: 1) Perform lineage tracing to test if LGR4, LGR5, and LGR6 mark connective tissue stem cells...

EPITENON-DERIVED PROGENITOR CELLS IN TENDON HEALING AND ADAPTATION - PROJECT SUMMARY THOUGH THOUGHT TO SERVE MANY IMPORTANT FUNCTIONS IN OVERALL TENDON FUNCTION, INCLUDING FACILITATING BOTH HEALING AND ADAPTATION TO MECHANICAL LOAD, THE TRUE IDENTITY AND FUNCTION OF THE EPITENON HAS REMAINED ELUSIVE DUE TO A LACK OF GENETIC MARKERS THAT SPECIFICALLY TARGET EPITENON CELLS. IN PRELIMINARY STUDIES, WE IDENTIFIED A NOVEL POPULATION OF GLAST-LINEAGE (GLASTU') CELLS IN THE EPITENON THAT CONTRIBUTE TO BOTH TENDON HEALING FOLLOWING ACUTE INJURY AND TENDON ADAPTATION IN RESPONSE TO MECHANICAL OVERLOAD BY DIFFERENTIATING INTO SCLERAXIS (SCX)EXPRESSING TENOCYTES. IDENTIFICATION OF A GENETIC MARKER FOR EPITENON CELLS AS WELL AS DEMONSTRATION OF THEIR CAPACITY FOR TENOGENIC DIFFERENTIATION HAS OPENED AN EXCITING NEW AVENUE OF TENDON RESEARCH WITH THE LONG-TERM GOAL OF UNDERSTANDING THE ROLE THAT EPITENON CELLS PLAY IN REGULATING OVERALL TENDON HOMEOSTASIS AND TO IDENTIFY WAYS TO LEVERAGE EPITENON CELL BEHAVIOR TO IMPROVE TENDON HEALTH. DURING THE K99 PHASE OF THIS AWARD, WE ESTABLISHED VOLUNTARY WHEEL RUNNING AS A TOOL FOR MODELING ADAPTIVE TENDON GROWTH IN MICE AND GENERATED NUMEROUS SOPHISTICATED GENETIC MOUSE MODELS TO FACILITATE THE STUDY OF HOW GLASTU" EPITENON PROGENITORS AND SEX-EXPRESSING TENOCYTES COORDINATE TO AFFECT TISSUE-LEVEL ADAPTATION. TO FURTHER EXPLORE THIS RELATIONSHIP DURING R00 PHASE OF THIS AWARD, THE PROPOSED STUDIES BUILD ON OUR PRIOR WORK TO TEST THE CENTRAL HYPOTHESIS THAT GLAS TU" EPITENON CELLS ARE AN INDISPENSABLE SOURCE OF TENOGENIC PROGENITOR CELLS FOR TENDON ADAPTATION AND THAT SIGNALING BETWEEN EPITENON CELLS AND TENOCYTES IS CRITICAL FOR THE TENOGENIC RESPONSE OF GLASTLIC PROGENITORS. COMBINING GENETIC LINEAGE TRACING WITH INTEGRATED SPATIAL/SINGLE-CELL RNA-SEQUENCING, WE WILL CREATE A COMPREHENSIVE SPATIAL AND TEMPORAL ATLAS THAT DEFINES THE PATHWAYS REGULATING THE COORDINATED MECHANORESPONSE OF EPITENON CELLS, TENOCYTES, AND GLASTU" PROGENITOR CELLS (AIM 1A), TO MECHANISTICALLY TEST THE HYPOTHESIS THAT COORDINATION BETWEEN EPITENON CELLS AND TENOCYTES IS REQUIRED FOR THE PROPER TENDON ADAPTIVE RESPONSE TO LOAD, WE WILL INDUCIBLY DEPLETE EITHER EPITENON CELLS OR TENOCYTES PRIOR TO TENDON LOAD IN COMPLEMENTARY EXPERIMENTS (AIM 1 B) AND ASSESS HOW DISRUPTION OF GLASTU, EPITENON CELL/TENOCYTE COMMUNICATION AFFECTS THE OVERALL TENDON ADAPTIVE RESPONSE. COLLECTIVELY, THESE DATA WILL PROVIDE THE FIRST COMPREHENSIVE CHARACTERIZATION OF EPITENON CELLS AND THEIR FUNCTION IN TENDON BIOLOGY.

Posted 5/16/24, 12:00 AM